Mathieu Peyrou

761 total citations
22 papers, 570 citations indexed

About

Mathieu Peyrou is a scholar working on Pharmacology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mathieu Peyrou has authored 22 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Epidemiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mathieu Peyrou's work include Endoplasmic Reticulum Stress and Disease (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Heart Failure Treatment and Management (3 papers). Mathieu Peyrou is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Heart Failure Treatment and Management (3 papers). Mathieu Peyrou collaborates with scholars based in Switzerland, France and Canada. Mathieu Peyrou's co-authors include Alastair E. Cribb, Paul Hanna, Shanmugam Muruganandan, Jérôme M. Giraudel, Jonathan P. Mochel, Meindert Danhof, Martin Fink, Mark Deurinck, Alain Bousquet‐mélou and Michèle Doucet and has published in prestigious journals such as Journal of the American College of Cardiology, Molecules and Pharmaceutical Research.

In The Last Decade

Mathieu Peyrou

21 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Peyrou Switzerland 13 138 133 131 100 84 22 570
Lori Mixson United States 15 39 0.3× 75 0.6× 191 1.5× 139 1.4× 98 1.2× 26 700
Jayesh B. Majithiya United Kingdom 14 36 0.3× 115 0.9× 202 1.5× 299 3.0× 47 0.6× 21 885
Stuart Levin United States 16 23 0.2× 96 0.7× 273 2.1× 99 1.0× 97 1.2× 41 913
Hamid Amouzadeh United States 13 54 0.4× 63 0.5× 173 1.3× 87 0.9× 38 0.5× 31 939
J.W.O. van den Berg Netherlands 22 121 0.9× 42 0.3× 328 2.5× 269 2.7× 25 0.3× 52 1.3k
Hong Min Kim South Korea 19 108 0.8× 26 0.2× 286 2.2× 321 3.2× 35 0.4× 34 892
Milinda E. James United States 12 49 0.4× 39 0.3× 223 1.7× 72 0.7× 158 1.9× 17 756
Anabel García‐Heredia Spain 19 15 0.1× 104 0.8× 175 1.3× 103 1.0× 57 0.7× 40 752
Tamotsu Matsuhashi Japan 17 40 0.3× 36 0.3× 224 1.7× 73 0.7× 20 0.2× 62 823
Mari Kawai Japan 15 21 0.2× 68 0.5× 252 1.9× 75 0.8× 56 0.7× 26 926

Countries citing papers authored by Mathieu Peyrou

Since Specialization
Citations

This map shows the geographic impact of Mathieu Peyrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Peyrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Peyrou more than expected).

Fields of papers citing papers by Mathieu Peyrou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Peyrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Peyrou. The network helps show where Mathieu Peyrou may publish in the future.

Co-authorship network of co-authors of Mathieu Peyrou

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Peyrou. A scholar is included among the top collaborators of Mathieu Peyrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Peyrou. Mathieu Peyrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peyrou, Mathieu, et al.. (2024). Comparison of an injectable toltrazuril–gleptoferron and an oral toltrazuril + injectable gleptoferron in piglets: Hematinic activities and pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics. 47(6). 492–502.
2.
3.
Pelligand, Ludovic, et al.. (2020). Population Pharmacokinetics and Pharmacodynamics Modeling of Torasemide and Furosemide After Oral Repeated Administration in Healthy Dogs. Frontiers in Veterinary Science. 7. 151–151. 8 indexed citations
4.
Mochel, Jonathan P., et al.. (2018). Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation. European Journal of Pharmaceutical Sciences. 128. 103–111. 20 indexed citations
5.
Mochel, Jonathan P., Martin Fink, Mathieu Peyrou, et al.. (2014). Influence of feeding schedules on the chronobiology of renin activity, urinary electrolytes and blood pressure in dogs. Chronobiology International. 31(5). 715–730. 36 indexed citations
6.
Mochel, Jonathan P., Martin Fink, Mathieu Peyrou, et al.. (2014). Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs. Pharmaceutical Research. 32(6). 1931–1946. 22 indexed citations
7.
Mochel, Jonathan P., Bryan F. Burkey, Martin Fink, et al.. (2014). FIRST-IN-CLASS ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR LCZ696 MODULATES THE DYNAMICS OF THE RENIN CASCADE AND NATRIURETIC PEPTIDES SYSTEM WITH SIGNIFICANT REDUCTION OF ALDOSTERONE EXPOSURE. Journal of the American College of Cardiology. 63(12). A806–A806. 3 indexed citations
8.
Mochel, Jonathan P., Martin Fink, Mathieu Peyrou, et al.. (2013). Chronobiology of the renin-angiotensin-aldosterone system in dogs: relation to blood pressure and renal physiology. Chronobiology International. 30(9). 1144–1159. 32 indexed citations
9.
Fink, Martin, Mathieu Peyrou, Jonathan P. Mochel, et al.. (2013). Population pharmacokinetic analysis of blood concentrations of robenacoxib in dogs with osteoarthritis. Research in Veterinary Science. 95(2). 580–587. 19 indexed citations
10.
Baynes, Ronald E., Jim E. Riviere, Thomas Franz, et al.. (2012). Challenges obtaining a biowaiver for topical veterinary dosage forms. Journal of Veterinary Pharmacology and Therapeutics. 35(s1). 103–114. 6 indexed citations
11.
Mochel, Jonathan P., Mathieu Peyrou, Martin Fink, et al.. (2012). Capturing the dynamics of systemic Renin‐Angiotensin‐Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs. Journal of Veterinary Pharmacology and Therapeutics. 36(2). 174–180. 19 indexed citations
12.
Mohamed, Rayane, et al.. (2012). Validation of a dried blood spot LC–MS/MS approach for cyclosporin A in cat blood: Comparison with a classical sample preparation. Journal of Pharmaceutical and Biomedical Analysis. 66. 298–305. 12 indexed citations
13.
Silber, Hanna E., Mathieu Peyrou, Martin Jung, et al.. (2010). Population Pharmacokinetic Analysis of Blood and Joint Synovial Fluid Concentrations of Robenacoxib from Healthy Dogs and Dogs with Osteoarthritis. Pharmaceutical Research. 27(12). 2633–2645. 22 indexed citations
14.
Peyrou, Mathieu & Alastair E. Cribb. (2007). Effect of endoplasmic reticulum stress preconditioning on cytotoxicity of clinically relevant nephrotoxins in renal cell lines. Toxicology in Vitro. 21(5). 878–886. 61 indexed citations
15.
Peyrou, Mathieu, Paul Hanna, & Alastair E. Cribb. (2007). Calpain Inhibition but not Reticulum Endoplasmic Stress Preconditioning Protects Rat Kidneys from p-Aminophenol Toxicity. Toxicological Sciences. 99(1). 338–345. 8 indexed citations
16.
Peyrou, Mathieu, Paul Hanna, & Alastair E. Cribb. (2007). Cisplatin, Gentamicin, and p-Aminophenol Induce Markers of Endoplasmic Reticulum Stress in the Rat Kidneys. Toxicological Sciences. 99(1). 346–353. 120 indexed citations
17.
Peyrou, Mathieu, Alain Bousquet‐mélou, Valérie Laroute, André Vrins, & Michèle Doucet. (2006). Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first‐pass effect and absorbed fraction. Journal of Veterinary Pharmacology and Therapeutics. 29(5). 337–344. 19 indexed citations
18.
Cribb, Alastair E., et al.. (2005). The Endoplasmic Reticulum in Xenobiotic Toxicity. Drug Metabolism Reviews. 37(3). 405–442. 116 indexed citations
19.
Peyrou, Mathieu, Michèle Doucet, André Vrins, et al.. (2004). Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. Journal of Veterinary Pharmacology and Therapeutics. 27(5). 283–288. 18 indexed citations
20.
Peyrou, Mathieu, et al.. (2003). Evolution de la résistance bactérienne enverscertains agents antibactériens chez les chevauxdans un centre hospitalier vétérinaire.. PubMed Central. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lori Mixson Breakdown of academic impact, for papers by Jayesh B. Majithiya Breakdown of academic impact, for papers by Stuart Levin Breakdown of academic impact, for papers by Hamid Amouzadeh Breakdown of academic impact, for papers by J.W.O. van den Berg Breakdown of academic impact, for papers by Hong Min Kim Breakdown of academic impact, for papers by Milinda E. James Breakdown of academic impact, for papers by Anabel García‐Heredia Breakdown of academic impact, for papers by Tamotsu Matsuhashi Breakdown of academic impact, for papers by Mari Kawai
Rankless by CCL
2026